| Agency | Primary Investigator | Title | Dates |
Total Award |
| New Grants FY 2008-2009 | ||||
| AHA Scientist Development Grant | L. Li | Type I and Type II NKT Cells: Immmunity and Tolerance in Kidney | 07/01/2008-06/30/2012 |
$308,000 |
| National Kidney Foundation | A. Bajwa | Role of Sphingosine-1-P receptor agonist in renal ischemic reperfusion injury | 07/01/2008-06/30/2010 |
$100,000 |
| New Grants FY 2007-2008 | ||||
| National Institutes of Health RO1 DK62324 | M. D. Okusa | Leukocyte Trafficking in Acute Renal Failure | 02/01/2008-01/31/2012 |
$1,287,752 |
| Genzyme (Genzyme Renal Innovations Program) | M. D. Okusa | Title Kidney resident dendritic cells activate the IL-12/IFN-γ and IL-23/IL-17 axis initiating early renal IRI |
09/01/2007-08/31/2010 |
$150,000 |
| National Institutes of Health R21DK077372 | W. K. Bolton | Growth hormone secretagogue MK-677 therapy in CKD and ESRD | 07/01/2007-06/30/2009 |
$416,625 |
| National Institutes of Health | W. K. Bolton | Experimental Autoimmune Nephritis: Epitope Spreading in Pathogenesis and Control | 02/07/2008-01/31/2012 |
$1,262,769 |
| National Institutes of Health K23 DK074616-01 | K. Kalantarinia | Adenosine 2A Receptor Agonist in Diabetic Nephropathy | 07/01/2007-06/30/2012 |
$523,264 |
| National Institutes of Health 1K99DK077444-01A1 | A. Awad | Podocyte Microenvironment in Diabetic Nephropathy | 09/01/2007-08/31/2009 |
$182,000 |